HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Longitudinal analysis of late vaginal mucosal reactions after high-dose-rate brachytherapy in patients with gynecological cancer.

AbstractAIM:
To longitudinally examine the late vaginal mucosal reactions in patients following high-dose-rate brachytherapy (BT).
PATIENTS AND METHODS:
We examined late vaginal mucosal reactions in 100 patients using the modified Dische score at 6, 12, 18, 24, 36, and 60 months after treatment, which consisted of 37 interstitial BTs and 63 conventional intracavitary BTs, with a median follow-up of 41 months (range=6-144 months).
RESULTS:
There were no cases of lethal toxicity or severe toxicity requiring surgery. Bleeding or discharge grade 1 or more was exhibited by fewer than 2-4% of patients, and in most cases only until 1.5 years following treatment. Erythema was detected in approximately 30% (mainly grade 1) of the patients up to five years. With regard to ulceration, four patients (7%) developed superficial ulceration; however, no patient had ulceration lasting six months or longer. Telangiectasia increased gradually over time in approximately 91% of patients (grades 1 and 2=73% and 18%, respectively) in the five years following treatment. The pallor reaction also increased over time in 100% of patients (grades 1, 2, and 3=30%, 48%, and 22%, respectively) in the five years after treatment. Stenosis also increased with time in approximately 97% of patients (grades 1, 2, and 3=29%, 61%, and 7%, respectively) over five years. There was a close correlation between pallor reaction and stenosis.
CONCLUSION:
High-dose-rate BT caused mild-to-moderate toxicities. Almost all patients showed pallor reaction, telangiectasia, and stenosis up to five years after treatment, and pallor reaction correlated with stenosis.
AuthorsKen Yoshida, Hideya Yamazaki, Satoaki Nakamura, Koji Masui, Tadayuki Kotsuma, Hironori Akiyama, Eiichi Tanaka, Yoshifumi Narumi, Yasuo Yoshioka
JournalAnticancer research (Anticancer Res) Vol. 34 Issue 8 Pg. 4433-8 (Aug 2014) ISSN: 1791-7530 [Electronic] Greece
PMID25075082 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Brachytherapy (adverse effects)
  • Female
  • Genital Neoplasms, Female (radiotherapy)
  • Humans
  • Longitudinal Studies
  • Middle Aged
  • Mucous Membrane (radiation effects)
  • Radiotherapy Dosage
  • Retrospective Studies
  • Vagina (radiation effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: